BIOQUAL INC - BIOQ STOCK NEWS

BIOQUAL (BIOQ) has announced its twenty-third dividend declaration. The company's Board of Directors has declared a dividend of $0.50 per share for shareholders of record on October 7, 2024. The dividend is payable on October 28, 2024.

This announcement demonstrates BIOQUAL's commitment to returning value to its shareholders. The dividend declaration suggests the company's financial stability and confidence in its future performance. However, it's important to note that past performance does not guarantee future results, and investors should consider their individual financial situations before making investment decisions.

BIOQUAL, Inc. (OTC Pink: BIOQ) has released its financial results for Fiscal Year 2024. The company reported:

• Revenue of $58,590,949, down from $62,663,804 in 2023
• Income Before Income Tax of $476,447, compared to $1,133,242 in 2023
• Net Income of $483,481, a decrease from $835,548 in 2023
• Basic and Diluted Earnings per Share of Common Stock both at $0.54, down from $0.93 in 2023

The Weighted Average Number of Shares Outstanding for both Basic and Diluted Earnings Per Share remained constant at 894,416.

BIOQUAL, Inc. (OTC: BIOQ) has announced a 10% reduction in workforce effective September 9, 2024, as a cost-cutting measure in response to decreased revenue and profitability over the past year. The company attributes this decline to a significant drop in demand for its services in the post-COVID-19 environment, following the development of vaccines and therapeutics.

Despite this workforce reduction, BIOQUAL does not anticipate any impact on its current services or future business prospects. The company aims to realign its cost structure to adapt to the changing market conditions while maintaining its operational capabilities.

BIOQUAL, Inc. (BIOQ) presents unaudited financial results for the third quarter of fiscal year 2024, showing revenue of $46,792,353 for nine months ended February 29, 2024. Net income increased to $1,659,170 compared to the same period last year. Income before income tax also saw growth. Visit www.bioqual.com for more details.

BIOQUAL, Inc. (BIOQ) reports a slight decrease in revenue for the six months ended November 30, 2023, compared to the same period in 2022. The company also experienced a decline in income before income tax and net income. Basic and diluted earnings per share of common stock also decreased. The unaudited second quarter results can be found on the company's website. Forward-looking statements are subject to risks and uncertainties.

BIOQUAL, Inc. reports its unaudited first quarter results for fiscal year 2024.

BIOQUAL declares dividend of $0.50 per share, 22nd dividend declared. Forward-looking statements caution investors. Risks include contract extensions, obtaining new contracts, demand for animal models, employee availability, contract performance, costs management, dependence on third parties, capital needs, financing availability and cost.

BIOQUAL, Inc. reports a decrease in revenue and income compared to the previous year.

BIOQUAL, Inc. (OTC Pink: BIOQ) reported its unaudited financial results for the third quarter ended February 28, 2023. The company generated revenue of $46.6 million for the nine months, a slight decline from $47.8 million in the previous year. In the third quarter alone, revenue was $14.1 million, compared to $17.1 million in the same period of 2022. The income before tax decreased to $2.17 million from $4.77 million year-over-year, while net income showed a decrease to $1.54 million from $3.37 million. Basic earnings per share (EPS) fell to $1.72 from $3.77, with diluted EPS also declining to $1.72 from $3.77. The company faces ongoing challenges including reliance on government contracts and the need for sufficient animal models.